Metagenomi Therapeutics (MGX) Revenue (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Revenue of $1.25 million for Q1 2026, down 69.8% from $4.13 million a year earlier and down 68.1% from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Revenue (2023 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Metagenomi Therapeutics' Revenue came in at $22.33 million, down 50.7% year-over-year; for FY2025, it came in at $25.21 million, down 51.8% from FY2024.
- By year, Revenue came in at $52.3 million in FY2024 (+16.8%) and $44.76 million in FY2023.
- The Q1 2026 figure ranks as the lowest quarterly Revenue in data going back to Q1 2023.
- Year over year, Revenue has now declined in each of the last seven quarters, with an average decline of 28.4% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q2 2024 (growth of 76.5%); the low point was Q1 2026 (a decline of 69.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $3.91 million (Q4 2025), $8.66 million (Q3 2025) and $8.51 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Metagenomi Therapeutics | 30.49 Mn | -575.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 3.91 Mn |
| Sep 30, 2025 | 8.66 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 4.13 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Sep 30, 2024 | 11.51 Mn |
| Jun 30, 2024 | 20.01 Mn |
| Mar 31, 2024 | 11.16 Mn |
| Dec 31, 2023 | 12.40 Mn |
| Sep 30, 2023 | 12.36 Mn |
| Jun 30, 2023 | 11.34 Mn |
| Mar 31, 2023 | 8.66 Mn |
API Access
Metagenomi Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();